Rigel Shareholders Again Lose Suit Over Arthritis Drug
A federal judge has dashed shareholders' second attempt to sue Rigel Pharmaceuticals Inc. over claims that the company knowingly omitted adverse results from tests on an experimental rheumatoid arthritis drug that...To view the full article, register now.
Already a subscriber? Click here to view full article